Clinical Trial Update: Phase I/II Study With Oral Panobinostat Maintenance Therapy Following Allogeneic Stem Cell Transplantation in Patients With High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]

View source ↗

Summary

This is a Phase I/II clinical trial evaluating oral panobinostat as maintenance therapy after allogeneic stem cell transplantation in patients with high-risk my…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Panobinostat (Panobinostat)

Snippet

Sponsor: Johann Wolfgang Goethe University Hospital | Conditions: Myelodysplastic Syndrome, Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: UNKNOWN